Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

LC-OCT helps accurately diagnose different types of infant hair loss without invasive methods.

New treatments for hair loss, like JAK inhibitors, PRP, anti-androgens, and minoxidil, offer better options.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

More research is needed to find the best long-term treatments for Alopecia Areata.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Phloroglucinol may help improve hair loss by promoting hair growth and reducing oxidative stress.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Glehnia littoralis and Andrographis paniculata extracts can significantly boost hair growth.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.